Exploratory analysis: biomarkers
In the subset of patients evaluated for biomarkers, maximal pERK inhibition in blood was observed at dose level 1 (~ 100% inhibition at 1 h postdose with return to near baseline levels after 3 days off treatment) and thus subsequent analyses were not deemed to provide additional information. Data regarding change in serum IL-8 were inconclusive owing to limited patient samples.